Search results
Results from the WOW.Com Content Network
However, Jamaican pediatrician Cicely Williams introduced the term in 1935, two years after she published the disease's first formal description. Williams was the first to research kwashiorkor and differentiate it from other dietary deficiencies. She was the first to suggest that this might be a protein deficiency.
Even diets of mild protein undernutrition (7.2%) have been shown to have lasting and significant effects in rats. The following are some studies in which prenatal protein deficiency has been shown to have unfavorable consequences. Decreased brain size: Protein deficiency has been shown to affect the size and composition of brains in rhesus monkeys.
Protein S deficiency is a disorder associated with increased risk of venous thrombosis. [1] Protein S , a vitamin K -dependent physiological anticoagulant, acts as a nonenzymatic cofactor to activate protein C in the degradation of factor Va and factor VIIIa .
Protein deficiency affects 1 billion people worldwide and causes symptoms like fatigue, thinning hair, and muscle wasting.
D-Bifunctional protein deficiency is an autosomal recessive peroxisomal fatty acid oxidation disorder. Peroxisomal disorders are usually caused by a combination of peroxisomal assembly defects or by deficiencies of specific peroxisomal enzymes. The peroxisome is an organelle in the cell similar to the lysosome that functions to detoxify the cell.
[11] [12] Specifically, it is a deficiency, excess, or imbalance of energy, protein and other nutrients which adversely affects the body's tissues and form. [13] Malnutrition is a category of diseases that includes undernutrition and overnutrition. [14] Undernutrition is a lack of nutrients, which can result in stunted growth, wasting, and ...
Mitochondrial trifunctional protein deficiency (MTP deficiency or MTPD) is an autosomal recessive fatty acid oxidation disorder [4] that prevents the body from converting certain fats to energy, particularly during periods without food. [5] [6]
GLUT1 deficiency syndrome, also known as GLUT1-DS, De Vivo disease or Glucose transporter type 1 deficiency syndrome, is an autosomal dominant genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier. [1]